Skip to search formSkip to main contentSkip to account menu

Org 32489

Known as: Org-32489 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

follitropin beta

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Recombinant FSH-induced follicle development in immature rats treated with an LHRH antagonist:a direct effect of RU486 on follicular atresia.
To investigate whether the progesterone antagonist RU486 has a direct effect on ovarian function, it was administered to immature… 
Highly Cited
1995
Highly Cited
1995
In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP.
In this study the in-vitro biopotency and glycoform distribution of human recombinant follicle stimulating hormone (FSH, Org… 
Highly Cited
1995
Highly Cited
1995
Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized…
The objective of this study was to compare the efficacy and safety of a recombinant follicle stimulating hormone (FSH… 
Highly Cited
1994
Highly Cited
1994
Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens.
In total, 50 couples participated in a pilot study evaluating the efficacy of various regimens of gonadotrophin-releasing hormone… 
1994
1994
Folliculogenesis in hypophysectomized rats after treatment with recombinant human follicle-stimulating hormone.
To examine the role of FSH and LH in follicular growth and atresia, immature hypophysectomized (hypox) rats were treated twice… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)